Literature DB >> 26767707

Current Evaluation of the Safety and Efficacy of Aneurysm Treatment with the WEB Device.

L Pierot, A Arthur, L Spelle, D Fiorella.   

Abstract

Entities:  

Year:  2016        PMID： 26767707      PMCID： PMC7960186          DOI： 10.3174/ajnr.A4702

Source DB:  PubMed          Journal:  AJNR Am J Neuroradiol        ISSN： 0195-6108            Impact factor:   3.825


× No keyword cloud information.
  9 in total

1.  WEB-DL endovascular treatment of wide-neck bifurcation aneurysms: short- and midterm results in a European study.

Authors:  B Lubicz; J Klisch; J-Y Gauvrit; I Szikora; M Leonardi; T Liebig; N P Nuzzi; E Boccardi; F D Paola; M Holtmannspötter; W Weber; E Calgliari; V Sychra; B Mine; L Pierot
Journal:  AJNR Am J Neuroradiol       Date:  2014-01-23       Impact factor: 3.825

2.  Results of embolization used as the first treatment choice in a consecutive nonselected population of ruptured aneurysms: clinical results of the Clarity GDC study.

Authors:  Christophe Cognard; Laurent Pierot; René Anxionnat; Frédéric Ricolfi
Journal:  Neurosurgery       Date:  2011-10       Impact factor: 4.654

3.  WEB Treatment of Intracranial Aneurysms: Clinical and Anatomic Results in the French Observatory.

Authors:  L Pierot; J Moret; F Turjman; D Herbreteau; H Raoult; X Barreau; S Velasco; H Desal; A-C Januel; P Courtheoux; J-Y Gauvrit; C Cognard; A Molyneux; J Byrne; L Spelle
Journal:  AJNR Am J Neuroradiol       Date:  2015-10-29       Impact factor: 3.825

4.  Mid-term anatomic results after endovascular treatment of ruptured intracranial aneurysms with Guglielmi detachable coils and Matrix coils: analysis of the CLARITY series.

Authors:  L Pierot; C Cognard; F Ricolfi; R Anxionnat
Journal:  AJNR Am J Neuroradiol       Date:  2011-10-27       Impact factor: 3.825

5.  Safety and efficacy of aneurysm treatment with WEB: results of the WEBCAST study.

Authors:  Laurent Pierot; Vincent Costalat; Jacques Moret; Istvan Szikora; Joachim Klisch; Denis Herbreteau; Markus Holtmannspötter; Werner Weber; Anne-Christine Januel; Thomas Liebig; Vojtech Sychra; Christoph Strasilla; Christophe Cognard; Alain Bonafé; Andrew Molyneux; James V Byrne; Laurent Spelle
Journal:  J Neurosurg       Date:  2015-09-18       Impact factor: 5.115

6.  WEB-DL Endovascular Treatment of Wide-Neck Bifurcation Aneurysms: Long-Term Results in a European Series.

Authors:  L Pierot; J Klisch; T Liebig; J-Y Gauvrit; M Leonardi; N P Nuzzi; F Di Paola; V Sychra; B Mine; B Lubicz
Journal:  AJNR Am J Neuroradiol       Date:  2015-07-30       Impact factor: 3.825

7.  Immediate clinical outcome of patients harboring unruptured intracranial aneurysms treated by endovascular approach: results of the ATENA study.

Authors:  Laurent Pierot; Laurent Spelle; Fabien Vitry
Journal:  Stroke       Date:  2008-07-10       Impact factor: 7.914

Review 8.  Endovascular Treatment of Intracranial Aneurysms with the WEB Device: A Systematic Review of Clinical Outcomes.

Authors:  X Armoiry; F Turjman; D J Hartmann; R Sivan-Hoffmann; R Riva; P E Labeyrie; G Aulagner; B Gory
Journal:  AJNR Am J Neuroradiol       Date:  2015-11-19       Impact factor: 3.825

9.  Clinical and Anatomical Follow-up in Patients With Aneurysms Treated With the WEB Device: 1-Year Follow-up Report in the Cumulated Population of 2 Prospective, Multicenter Series (WEBCAST and French Observatory).

Authors:  Laurent Pierot; Laurent Spelle; Andrew Molyneux; James Byrne
Journal:  Neurosurgery       Date:  2016-01       Impact factor: 4.654
  9 in total
  2 in total

1.  WEB Device Shape Changes in Elastase-Induced Aneurysms in Rabbits.

Authors:  Y Ding; D Dai; A Rouchaud; K Janot; S Asnafi; D F Kallmes; R Kadirvel
Journal:  AJNR Am J Neuroradiol       Date:  2020-12-10       Impact factor: 3.825

2.  Treatment of recurrent aneurysms using the Woven EndoBridge (WEB): anatomical and clinical results.

Authors:  Matthias Gawlitza; Sebastien Soize; Anne-Christine Januel; Cristian Mihalea; Georgios-Emmanouil Metaxas; Christophe Cognard; Laurent Pierot
Journal:  J Neurointerv Surg       Date:  2017-10-20       Impact factor: 5.836
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.